Evidence map›Paper›PMID 30665232›Full record

ArticleInvestigative ophthalmology & visual science2019

Selective Ablation of Megalin in the Retinal Pigment Epithelium Results in Megaophthalmos, Macromelanosome Formation and Severe Retina Degeneration.

Tina Storm, Thomas Burgoyne, Joshua L Dunaief, Erik I Christensen, Clare Futter, Rikke Nielsen

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Independent Mutations in theInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Review
  5. The role of inflammation in myopic retinopathy.Frontiers in ophthalmology · 2025
    Review
  6. Internalization of Angiotensin-(1-12) in Adult Retinal Pigment Epithelial-19 Cells.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. IMI 2021 Yearly Digest.Investigative ophthalmology & visual science · 2021
    Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Tina StormDepartment of Biomedicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark.
Thomas BurgoyneUCL Institute of Ophthalmology, London, United Kingdom.
Joshua L DunaiefF.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Erik I ChristensenDepartment of Biomedicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark.
Clare FutterUCL Institute of Ophthalmology, London, United Kingdom.
Rikke NielsenDepartment of Biomedicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark.
Aarhus University · DKUniversity College London · GBPenn Presbyterian Medical Center · US

Funding

Retinal Iron Transport in Health and DiseaseR01EY015240 · NEI · UNIVERSITY OF PENNSYLVANIA · PI JOSHUA L DUNAIEF · 2004 to 2026
$10.4M
Medical Research Council MR/P010091/1NEI NIH HHS R01 EY015240Wellcome TrustWellcome Trust 093445
6 · The paper itself

Abstract

Purpose: Mutations in the megalin-encoding gene, LRP2, cause high myopia as seen in patients suffering from Donnai-Barrow/facio-oculo-acoustico-renal syndrome. Megalin is present in both the nonpigmented epithelium of the ciliary body and in the RPE. In this study, we set out to establish an animal model to study the mechanisms underlying the ocular phenotype and to establish if high myopia/megaophthalmos is induced by postnatal megalin-deficiency in the RPE. Methods: Postnatal RPE-specific deletion of megalin was generated by crossing mice bearing a homozygous loxP-flanked Lrp2 allele with transgenic mice expressing the Cre recombinase driven by the BEST1 promotor. The model was investigated by immunohistologic techniques, and transmission electron microscopy. Results: Mice with postnatal RPE-specific loss of megalin developed a megaophthalmos phenotype with dramatic increase in ocular size and severe retinal thinning associated with compromised vision. This phenotype was present at postnatal day 14, indicating rapid development in the period from onset of BEST1 promotor activity at postnatal day 10. Additionally, RPE melanosomes exhibited abnormal size and morphology, suggested by electron tomography to be caused by fusion events between multiple melanosomes. Conclusions: Postnatal loss of megalin in the RPE induces dramatic and rapid ocular growth and retinal degeneration compatible with the high myopia observed in Donnai-Barrow patients. The morphologic changes of RPE melanosomes, believed to be largely inert and fully differentiated at birth, suggested a continued plasticity of mature melanosomes and a requirement for megalin to maintain their number and morphology.

Indexed as

AnimalsBestrophinsEye AbnormalitiesFemaleIntegrasesLow Density Lipoprotein Receptor-Related Protein-2MaleMelanosomesMiceMice, Inbred C57BLMice, TransgenicRetinal DegenerationRetinal Pigment EpitheliumBest1 protein, mouseBestrophinsCre recombinaseIntegrasesLow Density Lipoprotein Receptor-Related Protein-2Lrp2 protein, mouse

Identifiers

PMID30665232
PMCPMC6343679
OpenAlexW2912937793

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.